Q1 2025 Management View CEO Michael Olosky reported net sales of $538.9 million for Q1 2025, reflecting modest growth in a challenging macroeconomic environment. North America contributed $420.7 ...

LYON—The Comac C919, China’s foray into the current-generation commercial narrowbody aircraft market, may receive its ...

That piecemeal paradigm could hinder Europe’s plan for spending more on defense, which has been given a jolt — and previously ...

Europe is a lucrative potential hunting ground for U.S. investors. Years of underperformance have meant bargains abound.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Carbon Analysis: Efficiency In Europe Vs. United States is published in Aviation Daily, an Aviation Week Intelligence Network ...

Investors hope for more progress on tariff deals. Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

Ageas has Poor financial health. At year-end 2024 Ageas operated with EUR 4.296 billion of debt on its balance sheet. That is split between EUR 1.9 billion of borrowings and EUR 2.4 billion of ...

Negative power prices, while beneficial for some consumers in some countries, generally discourage investments in new ...

Germany is opposing a recommendation from a new report to divide its single power market into five separate bidding zones.

The world economy appears to be fragmenting, posing the biggest risk to markets currently as it brings low growth and higher ...

Alnylam Pharmaceuticals said its RNAi therapeutic vutrisiran received a positive opinion recommending approval from the Committee for Medicinal Products for Human Use of the European Medicines Agency.